2005年10月
Mitochondrial delivery of mastoparan with transferrin liposornes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy
INTERNATIONAL JOURNAL OF PHARMACEUTICS
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 303
- 号
- 1-2
- 開始ページ
- 1
- 終了ページ
- 7
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1016/j.ijpharm.2005.06.009
- 出版者・発行元
- ELSEVIER SCIENCE BV
Mastoparan (NIP), a potent facilitator of mitochondrial permeability transition (PT), could be used as an antitumor agent, if it were encapsulated in a tumor selective delivery system. We recently developed transferrin-modified liposomes (Tf-L) with a pH-sensitive fusogenic peptide (GALA), which delivers an encapsulated fluorescent marker into cytosol efficiently. In this study, we encapsulated NIP into Tf-L with GALA for the selective delivery to mitochondria of tumor cells. The NIP showed potent PT activity at concentrations above 25 mu M in a homogenate of K 562 cells as well as in isolated mitochondria in the presence of phosphate. Tf-L equipped with cholesteryl GALA can release encapsulated sulforhodamine B, while Tf-L failed, as evidenced by confocal laser scanning microscopy. The MP, which was delivered with Tf-L with GALA, released cytochrome c (cyt c) from mitochondria to the cytosol, while free NIP released cyt c not only to the cytosol but also extracellulary. These results demonstrate the utility of MP in Tf-L with GALA for cancer therapy. (c) 2005 Elsevier B.V. All rights reserved.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.ijpharm.2005.06.009
- ISSN : 0378-5173
- CiNii Articles ID : 120003702858
- Web of Science ID : WOS:000232574400001